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The nucleus reuniens: a key node in the neurocircuitry of stress
and depression
V Kafetzopoulos1, N Kokras1,2, I Sotiropoulos3,4, JF Oliveira3,4, H Leite-Almeida3,4, A Vassalou1, VM Sardinha3,4,
Z Papadopoulou-Daifoti1,✠, OFX Almeida5, K Antoniou6, N Sousa3,4 and C Dalla1
The hippocampus and prefrontal cortex (PFC) are connected in a reciprocal manner: whereas the hippocampus projects directly
to the PFC, a polysynaptic pathway that passes through the nucleus reuniens (RE) of the thalamus relays inputs from the PFC
to the hippocampus. The present study demonstrates that lesioning and/or inactivation of the RE reduces coherence in the
PFC–hippocampal pathway, provokes an antidepressant-like behavioral response in the forced swim test and prevents, but does
not ameliorate, anhedonia in the chronic mild stress (CMS) model of depression. Additionally, RE lesioning before CMS abrogates
the well-known neuromorphological and endocrine correlates of CMS. In summary, this work highlights the importance of the
reciprocal connectivity between the hippocampus and PFC in the establishment of stress-induced brain pathology and suggests
a role for the RE in promoting resilience to depressive illness.
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INTRODUCTION
Disruption of the pathways linking the prefrontal cortex (PFC) and
hippocampus is thought to underlie major depressive disorder.1–4
The PFC receives a monosynaptic innervation from the ventral
CA1 and subiculum of the hippocampus and there is a
directionality in this communication because hippocampal activity
leads the activity in the PFC.5,6 In contrast, the reciprocal PFC
output to the hippocampus is not monosynaptic but relayed via
the nucleus reuniens (RE), a thalamic midline nucleus7 (Figures 1a
and b). The RE inﬂuences PFC and hippocampal activity,8,9
presumably by modulating oscillatory patterns between these
two brain structures.10,11
Although RE-dependent coordinated PFC–hippocampal activity
was recently linked to working and spatial memory, passive
avoidance learning and fear responses,8,12–14 no information on
the possible involvement of the RE on the appearance of and
recovery from depressive-like symptoms is currently available.
We therefore investigated the possible involvement of the RE in
depression using the chronic mild stress (CMS), a paradigm of
depressive-like behavior in rodents, and the Forced Swim Test
(FST), a paradigm for testing potential antidepressant interven-
tions. Moreover, we examined the impact of RE lesioning on the
synchronized activity of the PFC and hippocampus, as well as on
neuromorphological and endocrine correlates of depressive-like
behavior. These preclinical studies suggest that the RE occupies a
central position in the neurocircuitry that underpins depression.
MATERIALS AND METHODS
Animals
Adult male Wistar rats (3 months old, 300–350 g at the beginning of the
experiment) were used. All animals were housed under controlled light/
dark cycle (12:12 h, lights on at 0800 hours) and constant temperature/
humidity (22 °C/30–40%). Animals had ad libitum access to food and water,
unless dictated otherwise by speciﬁc test protocols; they were randomly
selected and allocated to treatment/surgery groups, except as otherwise
noted (see experiment 3). Animals were single-housed postsurgery.
Behavioral tests were carried out in the light phase. All behavioral
experiments and scoring, as well as neurobiological procedures were
performed by raters blind to the group allocation. Procedures on animal
experiments were reviewed and approved by the relevant local ethics
committee and studies were carried out in accordance with European
Union Directive 2010/63/EU on animal care and experimentation.
Surgical procedure for RE lesions. Animals were anesthetized by intraper-
itoneal (i.p.) injection of a mixture of ketamine and xylazine15 (100 and
10 mg kg− 1, respectively) and placed in a stereotaxic frame Q1(David Kopf
Instruments). The RE lesions were performed by injecting 0.6 μl of 100 mM
N-methyl-D-aspartate (in 0.1 M phosphate-buffered saline (PBS), pH= 7.4;
0.1 μl min− 1) or vehicle (0.1 M PBS, pH= 7.4) directly into the RE (+2.3 mm
AP, ± 1.7 mm ML, and − 6.2 mm DV from bregma);16,17 the syringe was left
in place for an additional 5 min to ensure adequate diffusion.16,18–20 The RE
was accessed at a mediolateral angle of 15° to avoid damage to midline
brain structures and vessels, and injections were alternated between left
and right angles of access to randomize possible lateralized brain
damage.21 Animals were closely monitored after surgery, returned to their
home cages and allowed to recover for 1 week before further testing.
Histological veriﬁcation of RE targeting. Brain sections were lightly stained
with cresyl violet or hematoxylin to verify correct placement of cannulae
and the extent of RE lesions. Lesion size (area) was estimated according to
the presence of characteristic signs of excitotoxic reaction (loss of neurons
or tissue, proliferation of microglial cells, pyknotic nuclei and accumulation
of hemosiderin).16 The area of the lesion, relative to the whole RE, was
estimated using the Stereoinvestigator software Q2(MicroBrightField), with
reference to the Paxinos and Watson atlas;17 data are shown in
Supplementary Figure S2. Animals with lesion ratios o50% were excluded
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from the analysis,16,19 and animals with a lesion covering ⩾ 10% of any
other brain area in the vicinity of the RE were likewise excluded. Rats with
sparing of the RE were excluded from the analysis (35% for the
electrophysiology experiment, 11% for the FST experiments and 8% for
the CMS experiments).14,16,19
Experiment 1: Electrophysiological studies in RE-lesioned rats
Animals (n=4 per group) were anesthetized (sodium pentobarbital
60 mg kg− 1, i.p., supplemented every 60 min throughout the experiment)
and placed in a stereotaxic frame (David Kopf Instruments); rectal
temperature was maintained at 37 °C by a homoeothermic blanket
(Stoelting, Dublin, Ireland). To assess RE-modulated activation and
synchrony within the PFC and hippocampus pathway, platinum/iridium
recording electrodes (Science Products, Germany) wereQ3 placed in the
prelimbic frontal cortex and a concentric bipolar tungsten/stainless-steel
electrodeQ4 (WPI, USA) was positioned into the ipsilateral CA1/subicular
region of the ventral hippocampus (−3.3 mm AP, ± 0.8 mm ML, and
− 4.0 mm DV from skull for the PL; +6.5 mm AP, ± 5.5 mm ML, and
− 5.3 mm DV from skull for the hippocampus), as described previously.2,5,22
Recorded extracellular local ﬁeld potentials were ampliﬁed, ﬁltered (0.1–
300 Hz, LP511 Grass Ampliﬁer, Astro-Med, Rodgau, Germany), acquired
(Micro 1401 mkII, CED, UK) andQ5 recorded at a sampling rate of 1000 Hz on a
personal computer running the Signal Software (CED). After the electro-
physiological protocols, a biphasic 1 mA stimulus was delivered to both
electrodes. Thereafter, rats were killed and perfused with 4% paraformal-
dehyde (PFA) to verify correct placement of the recording electrodes (also
see below); data from animals in which electrodes were misplaced were
discarded.
Experiment 2: FST in the presence of RE lesion or RE inactivation
Forced swim test. The FST, a standard test for screening the antidepres-
sant potential of various interventions, was carried out as previously
described.23–27 Brieﬂy, 1 week after surgical lesions or transient pharma-
cological inactivation of the RE, rats were placed in a cylindrical tank
(60× 19 cm2, ﬁlled to a height of 40 cm with water at a temperature of
24± 1 °C) and were forced to swim for 15 min during a pretest (training)
session. After 24 h, animals were subjected to a 5 min swimming session
(test session).28 Sertraline was added in this experiment, as a positive
control, and sham-operated animals were given an i.p. injection of the
antidepressant sertraline (10 mg kg− 1) or vehicle 23, 5 and 1 h before the
FST test session (n= 8–12 per group).29,30
RE inactivation. To investigate whether temporary RE inactivation would
have the same effects in the FST as permanent RE lesions, a different set of
rats was used for RE inactivation studies during FST (n= 8 per group). For
RE inactivation, injection needles were introduced via a stainless steel
guide cannula (0.4 mm in diameter) implanted in the RE (1.0 mm above
the targeted site to allow the tip of the infusion needle to protrude into the
tissue).21 Five minutes before the FST pretest or test session, 0.6 μl of
tetracaine Q6(Sigma; 2% w/v dissolved in PBS)14 was slowly infused (3.5 min;
0.2 μl min− 1) to prevent tissue damage using a micropump (CMA-100;
CMA/Microdialysis).14,19 To facilitate postmortem evaluation of RE inactiva-
tion, 1% w/v cresyl violet was added in the tetracaine solution used for
inactivation.14,16,19
Open ﬁeld (OF) test. This test was used to assess the impact of surgical RE
lesions on locomotor activity. For this, an OF apparatus (square arena
43.2× 43.2 cm2) surrounded by tall Perspex walls (Med Associates, St
Albans City, VT, USA) was used. Sham-operated and RE-lesioned animals
were placed in the center and allowed to explore the area for 10 min.
Infrared beams and the manufacturer’s software were used to auto-
matically register exploration of the arena.23
c-FOS immunostaining. To investigate whether the RE is activated
following swim stress, c-FOS immunostaining31 was performed on brain
sections from sham-operated rats exposed to the FST. Brieﬂy, 90 min after
the last FST session, animals (n= 5 per group) were anesthetized and
perfused with 4% PFA (in 0.1 M PBS) before careful excision of the brain,
postﬁxation (4% PFA) and transfer to 30% sucrose (in PBS 0.1 M). After
incubation in 0.3% Triton X-100/0.1 M glycine/10% fetal bovine serum,
50 μm sections were cut on a vibratome and incubated with c-FOS
antibody (1:10 000; overnight, cat. no. PC05, Calbiochem, Darmstadt,
Germany). Sections were then incubated in biotinylated goat anti-rabbit
antibody (cat. no. E0432, Dako, Glostrup, Denmark) and Avidin/Biotin
Complex (ABC solution; Vectorstain Elite, Burlingame, CA, USA). Neurons in
the RE that were c-FOS-immunoreactive were counted using the
StereoInvestigator software (MicroBrightField). Immunoreactive c-FOS
was visualized with diaminobenzidine before light counterstaining with
hematoxylin. For double-labeling experiments, c-FOS was detected by
Figure 1. Nucleus reuniens (RE) lesion impacts on the function of prefrontal cortex (PFC)–hippocampus circuitry. (a) Schematic representation
of PFC–RE–hippocampus circuitry. (b) An atlas reference diagram and a slice photomicrograph of the RE lesion. (c, d) Overall CA1 and PFC
activity as measured by power spectrum densities was comparable in the sham and lesion groups. (e) PFC–hippocampus coherence was
decreased in lesioned rats, in comparison to sham controls.+denotes a signiﬁcant lesion effect, Po0.05.
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immunoﬂuorescence. For this, antigen retrieval was achieved using the
citrate buffer before overnight incubation (4 °C) of 50 μm sections
(vibratome-cut) with antisera against c-FOS (1:500; cat. no. AB1584Q7 ,
Millipore, USA) and calretinin (1:500; cat. No. AF5065, R&D Systems, USA)
and counterstaining with 4′,6-diamidino-2-phenylindole (1 μg ml− 1).
Labeled cells in the RE were counted using anQ8 Olympus BX51 microscope.
Experiment 3: Effects of CMS in RE-lesioned rats
Chronic mild stress. A slightly modiﬁed version of a previously described
CMS protocol32–35 was used in RE-lesioned rats, in order to investigate the
role of the RE in this model of depression (see Supplementary Table 1).
Four groups of animals (control/sham-operated, n=15; control/RE-
lesioned, n=12; CMS/sham-operated, n= 14; and CMS/RE-lesioned,
n= 13) were used. During the last 3 weeks of CMS, each of these groups
was subdivided (n= 6–8 per group); one half of each subgroup received
daily i.p. injections of the antidepressant sertraline (10 mg kg− 1 day− 1, as a
positive control) while the other half received vehicle (0.9% saline i.p.).
Sucrose preference test (SPT). Anhedonia, a core symptom of depression,
was monitored using the SPT on a weekly basis after initiation of the CMS
protocol.33,36 Animals that had been food and water deprived (18 h) were
presented with two preweighed bottles, one containing a 1% sucrose
solution and the other containing tap water, over a period of 1 h. Sucrose
preference was calculated according to the formula: sucrose preference=
(sucrose intake/(total ﬂuid intake)) and expressed as a percentage.
Following collection of sucrose preference data at week 0 (baseline),
animals were assigned to the control and CMS groups, as before.32,35
Brieﬂy, rats were assigned to the control and CMS groups alternating from
highest to lowest preference, so as the difference of means between the
two groups would be the lowest possible.
OF test and FST. Twelve hours after the end of the CMS protocol, all
animals were subjected to the OF test to monitor locomotor activity and
24 h later to the FST, as described above (experiment 2).
Tissue collection. Rats were anesthetized (pentobarbital) and PFA-
perfused immediately after the second (test) session of the FST; just
before the perfusion, a blood sample was withdrawn (under anesthesia)
from the right ventricle of the heart for the eventual assay of
corticosterone using a commercially available kit (ICN Biomedical, Costa
Mesa, CA, USA; inte-assay coefﬁcient of variation: 8%).25,32,37 Adrenals were
carefully dissected and weighed upon killing (Supplementary Figure S4).
Neurostructural analysis. To investigate the role of the PFC–hippocampus
circuit in CMS-induced neuromorphological changes, rats exposed to CMS
and their corresponding controls were perfused with saline; brains were
collected and immersed in Golgi–Cox solution for 14 days before transfer
to a 30% sucrose solution. Coronal vibratome sections (200 μm) were
collected in 6% sucrose, dried onto gelatin-coated microscope slides,
alkalinized in 18.7% ammonia, developed in Dektol (Kodak, Linda-a-Velha,
Portugal), ﬁxed, dehydrated and mounted, as previously described.33,38,39
Dendritic arborization, spine density and spine shape of neurons in the RE
and layer II/III of the prelimbic area of the mPFC (n=5 for all groups; 6
neurons per each animal) were subsequently analyzed. Brieﬂy, for each
selected neuron, all branches of the dendritic tree were reconstructed
using a motorized microscope (Axioplan 2; Carl Zeiss) andQ9 the Neurolucida
software (MicroBrightField) and the dendritic length was automatically
calculated. Dendritic spine density (number of spines/dendritic length) was
determined in the proximal (60–120 μm) and distal (140–200 μm) parts of
the apical dendritic tree. To assess changes in spine morphology, spines in
the selected segments were classiﬁed into mushroom-shaped, thin, wide
and ramiﬁed spines, according to Harris;40 the proportion of spines in each
category was calculated for each neuron. A Sholl analysis (index of
dendritic complexity and degree of arborization) was also conducted; the
number of dendritic intersections with concentric spheres positioned at
radial intervals of 20 μm from the soma was assessed using NeuroExplorer
software (MicroBrightField), as previously described.33
Experiment 4: Effects of RE lesioning before vs during exposure to
CMS
Chronic mild stress. The next CMS experiment followed the same protocol
as described above in experiment 3. The purpose of this experiment was to
investigate whether RE lesions can prevent or reverse CMS-induced
changes. A new set of animals were given a sham operation or an RE
lesion, and 1 week later, they were subjected to CMS. Four weeks into the
CMS, the protocol was suspended and previously sham-operated animals
were given a second sham operation or received an RE lesion. Rats were
allowed 3 days to recover from surgery and CMS resumed with the
resulting three experimental groups: 6 rats with RE lesion before CMS, 7
rats with RE lesion during CMS, and the remaining 9 sham-operated rats.
The CMS protocol continued for further 6 weeks and SPTs were performed
as described above.
Dexamethasone suppression test (DST). At the end of the CMS, a DST was
administered to all animals, in order to assess the glucocorticoid-negative
feedback sensitivity of the hypothalamus–pituitary–adrenal (HPA) axis.41
Brieﬂy, all animals received an injection of either dexamethasone
(100 μg kg− 1, i.p.) or vehicle (0.9% saline) before being subjected to a
swim stress (at 24 ± 1 °C) for 15 min. Two hours later, rats were killed and
blood samples were analyzed for corticosterone levels, as described above.
Data are presented as the relative percentage of changes of corticosterone
levels in the corresponding group pairs (dexamethasone-injected vs saline-
injected).41
Statistical analysis
Sample sizes were determined by power analysis, based on effects sizes
previously observed in previous similar experiments performed by the
authors, at 80% power and type I error equal to 5%. After testing for
normality and homogeneity, appropriate statistical tests were applied to
the data. Repeated-measures analysis of variance was used to analyze
results from the SPT. One-way, two-way and three-way analysis of variance
were used, as appropriate, to evaluate other behavioral data as well as
morphological, electrophysiological, hormonal and immunohistochemical
results. Differences between groups were then determined by Bonferonni’s
post hoc analysis. Signiﬁcance level was set at P= 0.05. All results are
expressed as mean± s.e.m.
Figure 2. Nucleus reuniens (RE) lesion exhibits antidepressant effect in Forced Swim Test (FST). (a) Lesion of RE before FST procedure and
alternatively a temporary RE inactivation either at the ‘pretest’ or ‘test’ swim session, prevented the appearance of depressive-like behavior by
reducing immobility duration in the second, ‘test’ swim session, similar to sertraline administration. (b) All RE activity manipulations
lengthened the active, swimming behavior, as sertraline did. (c) FST increased c-FOS-expressing neuron density in RE. *Denotes a signiﬁcant
stress effect, #a signiﬁcant treatment effect and +a signiﬁcant lesion effect, Po0.05.
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RESULTS
RE lesion impacts on the function of PFC–hippocampus circuitry
and elicits antidepressant-like effects
Network dynamics in the PFC–hippocampus loop were compared
between sham-operated and RE-lesioned rats by simultaneously
recording neuronal activity in the medial PFC and ventral
hippocampus. Power spectrum densities and coherence analyses,
based on local ﬁeld potentials, were used as indicators of power
activity and phase coherence between the PFC and
hippocampus.5,42 As shown on Figure 1, RE lesioning did not
alter overall activity in the hippocampus (Figure 1c) and PFC
(Figure 1d), evidenced by monitoring power spectrum densities at
several frequency bands. However, coherence between ﬁring in
the PFC and hippocampus was signiﬁcantly reduced in
RE-lesioned animals; speciﬁcally, as compared with their sham-
operated controls, RE-lesioned animals displayed reduced theta
and beta frequency bands; the same tendency was observed for
gamma frequency bands (Figure 1e; lesion main effect: theta:
F1,6 = 82.46, Po0.001; beta: F1,6 = 20.74, P= 0.004 and gamma:
F1,6 = 5.59, P= 0.056).
Using the FST, which is used widely to assess the antidepressant
potential of drugs and various interventions,43 we found that
RE-lesioned animals exhibited lower immobility levels than sham-
operated animals during the second FST session (Figure 2a).
Interestingly, the duration of immobility observed in RE-lesioned
animals was comparable to that observed in rats that received
sertraline, an antidepressant drug employed in this study as
positive control. Similar antidepressant effects were apparent
when the RE was transiently inactivated with tetracaine either
before the ‘pretest’ (ﬁrst) or ‘test’ (second) FST session (Figure 2a)
(inactivation main effect: F3,32 = 49.50, Po0.001; post hoc: lesion vs
sham Po0.001, ‘pretest’ inactivation vs sham Po0.001, ‘test’
inactivation vs sham Po0.001; main effect of sertraline treatment:
F1,18 = 50.68, Po0.001). Rats with transient inactivation (tetra-
caine-induced) or permanent excitotoxic lesion (N-methyl-D-
aspartate-induced) of the RE showed duration of swimming
behavior that was greater than that observed in sham-operated
rats. Moreover, swimming duration was comparable in RE-lesioned
and sertraline-treated animals (Figure 2b) (inactivation main effect:
F3,32 = 27.63, Po0.001, post hoc: lesion vs sham Po0.001, ‘pretest’
RE inactivation vs sham Po0.001, ‘test’ RE inactivation vs sham
P= 0.002; treatment main effect F1,18 = 51.29, Po0.001). Climbing
duration did not differ signiﬁcantly between any of the groups
(data not shown).
Complementing the above results, we observed in sham-
operated rats that FST activates the RE because there was an
increase in the density of c-FOS immunoreactive cells (Figure 2c;
FST main effect: F1,8 = 240.6, Po0.001). Interestingly, after the FST
the percentage of calretinin cells that co-expressed c-FOS did not
change signiﬁcantly (Supplementary Figure S2; FST main effect:
F1,6 = 2.465, P= ns).
Finally, RE lesion did not affect neither the locomotor activity,
measured by ambulation in an OF arena, nor the amount of time
spent in the center of the arena (lesion main effect: F1,19 = 0.20,
P=NS and F1,19 = 0.04, P=NS, respectively; Supplementary Figures
3a and b). These behavioral ﬁndings concur with previously
pubished observations.19
Role of RE in eliciting depressive-like behavior supported by
behavioral and neuromorphological measures
CMS is an acknowledged paradigm for inducing depressive-like
behavior in rodents.35 Anhedonia, which is a core symptom of
depression, can be modeled in rodents using the SPT, and in
agreement with numerous previous studies,23,32 the CMS para-
digm successfully decreased sucrose preference after 4 weeks.
Moreover, treatment with sertraline in the following 3 weeks
reversed the CMS-induced anhedonia (Figure 3a). Importantly,
lesions of the RE prior to exposure to the 7-week CMS paradigm
abrogated the CMS-induced anhedonia (time× CMS× lesion
interaction: F5,250 = 2.46, P= 0.034, CMS× treatment interaction
F1,47 = 4.97, P= 0.031, post hoc: sertraline–CMS vs vehicle–CMS
P= 0.025; Figure 3a).
The duration of immobility in the FST was enhanced by CMS
and decreased by sertraline in both control and CMS-exposed rats
(Figure 3b). Importantly, all RE-lesioned rats (control and CMS-
exposed) exhibited reduced immobility in the FST (CMS× treat-
ment× lesion interaction: F1,46 = 6.657, P= 0.013, post hoc: lesion–
vehicle–CMS vs sham–vehicle–CMS Po0.001, lesion–vehicle–
control vs sham–vehicle–control Po0.001, sertraline–sham–CMS
vs vehicle–sham–CMS Po0.001, sertraline–sham–control vs
vehicle–sham–control Po0.001, CMS–vehicle–sham vs control–
vehicle–sham P= 0.001). In addition, sertraline treatment and
RE lesioning increased the time spent swimming in control and
CMS rats (Figure 3c; treatment× lesion interaction: F1,46 = 19.83,
Po0.001, post hoc: lesion–vehicle vs sham–vehicle Po0.001,
sertraline–sham vs vehicle–sham Po0.001). Finally, sertraline and
RE lesioning reduced serum corticosterone levels (treatment and
lesion main effect: F1,46 = 4.64, P= 0.037 and F1,46 = 4.09, P= 0.049;
Supplementary Figure S5). Taken together, all ﬁndings show that
disruption of RE function prevents the establishment of
depressive-like behavior in CMS.
Consistent with the absence of CMS-induced depressive-like
behavior in RE-lesioned rats, these animals did not display
neurostructural changes in the PFC after CMS. Speciﬁcally, RE
lesioning prevented the atrophy of dendrites of PFC neurons that
follows exposure to CMS33 (Figures 4a and b; lesion×CMS
interaction: F1,32 = 7.14, P= 0.012, post hoc: lesion–CMS vs sham–
CMS P= 0.002, CMS–sham vs control–sham P= 0.002, n= 5 per
group). Similar to RE lesioning, sertraline also counteracted
Figure 3. Nucleus reuniens (RE) is essential for depressive behavior and neuronal deﬁcits induced by chronic stress. (a) RE lesion prevented
chronic mild stress (CMS)-induced decreased sucrose preference. Sertraline treatment at week 4 reversed CMS-induced decreased sucrose
preference. (b) CMS signiﬁcantly increased immobility duration. Sertraline reduced immobility only in sham-operated animals and RE lesion
resulted in decreased immobility only in vehicle-treated rats. (c) In contrast, RE lesion and sertraline increased swimming in control and CMS
rats. *Denotes a signiﬁcant stress effect, #a signiﬁcant treatment effect and +a signiﬁcant lesion effect, Po0.05.
Role of the nucleus reuniens
V Kafetzopoulos et al
4
Molecular Psychiatry (2017), 1 – 8 © 2017 Macmillan Publishers Limited, part of Springer Nature.
CMS-induced dendritic atrophy in PFC neurons (Figures 4a and b;
treatment×CMS interaction F1,32 = 5.47, P= 0.026, post hoc: sertra-
line–CMS vs vehicle–CMS P= 0.002, n= 5 per group). Sertraline
itself did not affect dendritic length of RE neurons (treatment main
effect: F1,16 = 0.69, P=NS, n= 5 per group), whereas there was a
tendency for CMS to increase dendritic length in RE neurons (CMS
main effect F1,16 = 3.94, P= 0.065) (Supplementary Figure S5).
Protection against CMS-induced reductions in PFC apical
dendrite spine density was another important effect that resulted
from either RE lesioning or sertraline treatment (lesion×CMS
interaction: F1,32 = 4.82, P= 0.035, post hoc: lesion–CMS vs sham–
CMS P= 0.006, sham–CMS vs sham–control Po0.001, treatment×
CMS interaction: F1,32 = 5.36, P= 0.027, post hoc: sertraline–CMS vs
vehicle–CMS P= 0.001, n= 5 per group; Figures 4c and d). As
shown in Figure 5, in sham-operated animals CMS slightly
reduced, whereas sertraline signiﬁcantly increased the percentage
of mushroom spines in the proximal part of apical dendrites in the
PFC (CMS main effect F1,16 = 4.38, P= 0.053; treatment main effect
F1,16 = 4.72, P= 0.045; Figure 5a). These effects were not evident in
RE-lesioned animals (CMS main effect F1,16 = 0.56, P=NS; treat-
ment main effect F1,16 = 3.04, P=NS; Figure 5a). Importantly,
whereas CMS decreased the relative number of mushroom spines,
RE lesions prevented this effect (post hoc: sham–CMS vs sham–
control P= 0.031; lesion–CMS vs lesion–control P=NS). Sertraline
increased the percentage of mushroom spines at the distal
segments of apical dendrites in all, but the CMS RE-lesioned
animals (post hoc control: sham–sertraline vs sham–vehicle
P= 0.004; lesion–sertraline vs lesion–vehicle P= 0.024; CMS:
sham–sertraline vs sham–vehicle P= 0.037).
Results from Sholl analyses showed that dendritic arborization
of the apical dendrites of PFC neurons was similarly increased by
both RE lesioning and sertraline treatment in comparison to sham-
operated and vehicle-treated rats, respectively (Figure 5e;
F2.47,78.90 = 3.36, P= 0.031 and F2.47,78.90 = 3.00, P= 0.045, lesion
and treatment main effect, respectively). Thus, similar to sertraline
treatment, RE lesions spare PFC neurons from CMS-induced
reductions in the dendritic complexity of PFC neurons.
RE lesions prevent, but do not mitigate, CMS effects
Having demonstrated that the manifestation of depressive-like
behavior after CMS depends on an intact RE, we next asked
whether the CMS-induced depressive-like behavior and HPA axis
dysregulation could be reversed or ameliorated by introducing RE
lesions not before but during CMS. In this second CMS
experiment, we successfully repeated our previous CMS ﬁnding,
as animals with an RE lesion before CMS exposure did not exhibit
anhedonia and had higher sucrose preference compared with
sham-operated animals (lesion main effect: F1,20 = 5.148, P= 0.034).
Interestingly, animals that received an RE lesion during CMS were
not different from sham-operated animals, thus exhibiting
anhedonia that did not appear if RE lesion was performed before
CMS (lesion main effect: F2,19 = 4.676, P= 0.022, post hoc: sham vs
pre-CMS lesion P= 0.032, sham vs during CMS lesion P= 1.0;
Supplementary Figure S6a). Moreover, CMS has been shown to
elicit HPA axis dysregulation44,45 similar to the one often seen in
depressed patients.46 Therefore, we employed the DST to monitor
the expected disruption of the negative feedback of the HPA axis
while under CMS.47 In accordance with the behavioral resilience to
CMS, animals with an RE lesion before CMS displayed a
suppressed corticosterone response following dexamethasone
despite CMS. Instead, sham-operated rats and rats that received
Figure 4. Chronic mild stress (CMS)-evoked dendritic deﬁcits of prefrontal cortex (PFC) neurons were attenuated by nucleus reuniens (RE)
lesion. (a) RE lesion prevented and sertraline reversed CMS-induced reduction of dendritic length of PFC neurons. (b) Depiction of three-
dimensional reconstructed cortical pyramidal neurons. Scale bar: 50 μm. (c) RE lesion also prevented the CMS-induced spine density decrease
at the apical dendrites of PFC neurons. (d) Representative photomicrographs of spine-bearing branches. The arrow indicates a thin spine and
the plus sign a mushroom spine; *denotes a signiﬁcant stress effect, #a signiﬁcant treatment effect and +a signiﬁcant lesion effect, Po0.05.
Scale bar: 5 μm.
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an RE lesion during CMS displayed the depressive-like non-
suppression in the DST (DST main effect: F2,6 = 23.529, P= 0.001,
post hoc: lesion before CMS vs sham: P= 0.003, lesion before CMS
vs lesion during CMS: P= 0.003; Supplementary Figure S6b). Taken
together, ﬁndings from this experiment suggest that the RE is
essentially involved in the establishment phase of depressive
symptomatology rather than in processes recruited for recovering
from depression.
DISCUSSION
The present experimental study provides novel evidence for the
intermediary, but pivotal, role of the RE in synchronizing
communication between the PFC and hippocampus. In this
regard, the data presented here support and extend previous
suggestions that the RE thalamic nucleus forms an integral part of
the PFC–hippocampal circuitry.8,9 Speciﬁcally, we show that the RE
is essential for maintaining phase coherence between the PFC and
the hippocampus. We also report that the RE has a crucial role in
the manifestation of a depressive-like state and related behavioral,
neuromorphological and endocrine effects. Although previous
authors suggested RE involvement in the processing of emotional
and cognitive information,11,48 our observations are important
because they pinpoint a neuroanatomical network that may be
targeted to increase resilience against mood disorders, such as
major depression.
The suggestion that the RE is implicated in the PFC/
hippocampus-dependent behavioral response is supported by
our ﬁnding that the FST paradigm, which enhances corticosterone
levels,25,49 leads to a signiﬁcant RE activation. This is in line with a
previous ﬁnding that a short exposure to an acute stressor
activates the RE50 and suggests a role of the RE in the stress
response. Also relevant is to notice that an earlier report showed
that antidepressant-like effects are elicited by lesions of the
ventral PFC;51 in our study, we triggered an antidepressant
response, namely, reduced immobility and increased swimming
Figure 5. Impact of nucleus reuniens (RE) lesion on spine morphology and dendritic arborization. (a) Chronic mild stress (CMS) marginally
reduced and sertraline clearly increased mushroom spine percentage in the proximal part of the apical dendrites in sham- but not in lesion-
operated rats. (b) In the distal portion, CMS sham-operated but not lesioned rats had decreased mushroom spine percentage. Sertraline
increased the mushroom percentage in all cases except CMS lesioned animals. (c) In the proximal portion of the apical dendrite in PFC
pyramidal neurons, CMS uniformly elevated thin spine percentage. (d) In the distal part, sertraline treatment reduced and CMS increased thin
spine percentage in sham-operated rats while in RE-lesioned rats sertraline decreased thin spine percentage only in controls. (e) RE lesion and
sertraline increased dendritic arborization. *Denotes a stress effect, #a treatment effect and +a lesion effect.
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duration in the FST and abrogation of anhedonia in the CMS,52 not
by lesioning the PFC but instead by lesioning a thalamic nucleus
at the interplay between PFC and hippocampus.
Notably, the RE lesion and antidepressant treatment triggered
behavioral responses of comparable effect size. However, it is
important to note that RE inactivation at any of the two FST
sessions (pretest and test) resulted in the same antidepressant-like
behavioral response. Interestingly, the anhedonia during CMS, the
depressive-like behavior in the FST after CMS and the disruption of
the HPA axis could only be prevented when the RE lesions
preceded CMS. In contrast, lesions of the RE midway through the
CMS protocol failed to reverse the behavioral and endocrine
anomalies induced by CMS. These observations point not only to
the critical role of the RE in the stress response and its detrimental
effects but may also relate to differences between the two models
(FST, CMS).52 Although CMS is known for its face and construct
validity, more closely modeling the human condition, the FST
excels for its predictive validity of potential antidepressant
manipulations, either before or in between the two FST sessions.
Importantly, along with the behavioral resilience, RE lesions also
prevented in the PFC the appearance of CMS-induced deﬁcits in
neuroplasticity (for example, dendritic atrophy and spine loss),
which have been associated with depressive-like behavior.33,53 It
should be noted here that the RE predominantly projects to
superﬁcial layers of the PFC,54 which are the most affected by
CMS.53,55–57 It is thus suggested that, in rats with an intact RE, the
depressive-like morphological (plasticity) changes observed after
CMS in PFC neurons may be a result of the CMS-induced change
on the PFC–hippocampus crosstalk. Importantly, antidepressant
(sertraline) treatment and RE lesion resulted in a similar
morphological alteration of plasticity indices, such as spine
density and dendritic arborization. This suggests that a PFC–
hippocampus decoupling and an antidepressant treatment may
partially share a common underlying mechanism of action,
however, with a signiﬁcant difference: PFC–hippocampus decou-
pling may prevent the establishment of depressive-like symptoms,
whereas antidepressant pharmacotherapy may prevent and
restore depressive-like symptoms in animal models of depression.
Moreover, our ﬁndings on the DST are consistent with the
experimental and clinical data, which demonstrate that often an
altered HPA axis negative feedback associates with the appear-
ance of depressive-like symptomatology.58 Taken together, these
ﬁndings show that the prevention of depressive-like behavior by
RE lesion extends not only to the behavioral response but also to
neuroendocrine and brain neuroplasticity ﬁndings that are highly
related to the pathophysiology of depression.
In light of the recently emerging view that chronic stress shifts
the overall brain connectome, it is relevant to examine the
involvement of RE on the suggested switch between circuitries
along the transition from acute stress condition to chronic stress
brain construct. For this purpose, it is relevant to explore the
contribution of different RE neuronal populations to this effect.
Previously, it was demonstrated that calretinin-stained neurons
project in the hippocampal CA1 region.59 In this study, calretinin
staining showed a high degree of co-localization with c-FOS-
activated cells, thus highlighting the involvement of RE glutamate
interneurons at the PFC–hippocampus communication. Lesioning
of these interneurons produced the resilience to depression
presented here. However, a limitation of this study is that, in
contrast to humans, rodents may be virtually devoid of GABA
interneurons in the RE relay nucleus.59,60 Thus it is not yet clear
whether disrupting both GABA and glutamate RE interneurons or
speciﬁcally the later subpopulation would replicate our ﬁndings in
humans. Finally, given the observed RE activation during FST in
sham-operated animals, an optogenetic-based approach for
activating RE during FST and /or CMS would also provide
additional insight.
In conclusion, the present work pinpoints the RE as an important
relay station in PFC–hippocampus communication and demon-
strates that the reﬁnement of cortical information ﬂow by this
speciﬁc thalamic nucleus is critical for mood regulation as well as
the establishment of depressive-like pathology.
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